2019第四届亚太医疗政策峰会 产业会议
会议标题 2019第四届亚太医疗政策峰会
会议时间 2019-05-10 到 2019-05-11
会议地点 新加坡
官方网址

4th Healthcare Policy Asia Pacific Summit 2019

2019第四届亚太医疗政策峰会


May 9-10, 2019 • Singapore


About 

关于


About this Event


Why attend HAP4? (event background)


The market for healthcare in the Asia Pacific region expanded at more than a 12% CAGR from 2012 to 2018, and strong growth is projected for the near future. With continued population growth, increased disposable incomes, and rapid urbanization, the Asia Pacific region is ripe with opportunity for global healthcare providers. However, as government policies and market conditions across the region differ substantially from those of the European and American markets, the continued development of the healthcare industry faces a set of unique challenges.


The 4th Asia Pacific Healthcare Summit 2019 will provide attendees with detailed information on the latest regulatory policies for healthcare across the Asia Pacific region, and offer a platform for healthcare industry professionals to share experiences, and express opinions on optimal business practices in the wake of changes within the industry.


What you will learn (highlights)

-More than 100 Delegates interpreting healthcare regulations in Singapore, Japan, South Korea, Thailand, India, Vietnam, and other major jurisdictions

-Firsthand testimony from government officials and industry leaders on healthcare policy in the APAC region and around the world, as well as future market trends

-Detailed look at the registration process and market access strategy for healthcare products.

-The latest knowledge on quality assurance and regulatory compliance for medical devices and pharmaceuticals

-In-depth analysis of product development and clinical trial requirements in the Asia Pacific region

-Information on cutting-edge innovationintegrating drugs with medical devices

-Challenges and opportunities for medical device supply chains and distributors

-Robust exchange between company representatives and government regulators, in the interest of developing the industry


Speakers   

演讲嘉宾


Speakers to Invite

Health Sciences Authority (HSA), Singapore

The Ministry of Food and Drug Safety (MFDS), Korea 

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

The Therapeutic Goods Administration (TGA), Australia

Food and Drug Administration (FDA), Thailand

Ministry of Health Vietnam

Ministry of Health Malaysia

Ministry of Health & Family Welfare (MOHFW), India 

World Health Organization (WHO)

The ASEAN Secretariat

Leading International Healthcare Companies


Attendees    

参会嘉宾


Who should attend?

By Industry 

• Pharmaceutical Companies

• Medical Device Companies

• Medical Merchandising

• Law Firm/Advisor Consulting

• Medical Services

• Insurance Companies

By Job Title

• Top Management

• Government Affairs Director/Manager

• Regulatory Affairs Director/Manager

• Registration Director/Manager

• Quality Assurance/ Compliance

• Medical Affairs Director/Manager

• Business & Marketing Director/Manager

• Public Relations Director/Manager

• External/Corporate Affairs Director/ Manager

• Legal Director/Manager


Some Previous Attendees 


3M Asia Pacific Pte Ltd.

Baxter International Inc.-Baxalta

Allergan Inc.

Aspen Pharmacare Holdings Limited

SANOFI PASTEUR

Astrazeneca

St. Jude Medical

Ipsen

Borouge

C. R. Bard

Bayer Healthcare

Fresenius Medical Care Asia- Pacific Ltd.

GSK (GlaxoSmithKline Pte Ltd)

Takeda Pharmaceutical Company Limited

Janssen Pharmaceuticals, Inc. Johnson & Johnson

Johnson & Johnson

Medtronic, Inc. 

Merck

MSD International

Sanofi

Mundipharma International

Philips

Linde Gas Asia Pte Ltd.

Novartis Asia Pacific Pharmaceuticals Pte Ltd.

Kimberly-Clark Health Care_ Halyard

Hologic, Inc.

Air Liquide (China) Holding Co., Ltd.

Cordis (Shanghai) Medical Devices Co., Ltd.

Shire Pharmaceuticals Group plc

Illumina

SchlafenderHase

SERVIER

Thermo Fisher Scientific Inc

Teva Pharmaceutical Industries Ltd.

Viveve

Baker & McKenzie

Beckman Coulter Danaher (Danaher Bernstein)

Biogen Idec

B. Braun Medical Industries SdnBhd

Cook South East Asia

Connexall


Schedule 

日程


Event Schedule


Thursday

May 9, 2019


Regulatory & Policy Environment in APAC Jurisdictions


Friday

May 10, 2019

Market Access and Regulatory Compliance

Clinical Trials and New Product Development

Procurement and Allocation

Quality Assurance and Quality Control


For further information, please contact:

Ms. Cindy CUI

Tel: + 86215258 8005 Ext. 8253


广告
游客需要先 登录 才能评论
评论(0)
暂无评论
独家报道
4月20日,药品管理法修订草案第二次提交十三届全国人大常...
2小时前 阅读: 1148
一周君览一周行业热点、市场动态:5大类产品“无缘”2019医...
2天前 阅读: 2921
药咖君看一周药品审评审批新动态:豪森又来1类“替尼”新药申报...
2天前 阅读: 3040
截止2019年4月18日,中国药企获得FDA批准的ANDA已...
2天前 阅读: 2819
截止4月18日,CDE受理一致性评价受理号达1054个(34...
5天前 阅读: 4316
截止2019年4月17日,CDE承办的一致性评价受理号已达1...
5天前 阅读: 4718
继4月12日吉林下发区域联采《征求意见稿》,引用广东省特别是...
6天前 阅读: 5030
为了应对多家仿制药生产商召回缬沙坦后所造成的市场短缺情况,F...
1星期前 阅读: 4868
药乾坤看一周地方热点、企业新动态:4月11日,2019恒瑞医...
1星期前 阅读: 5309
热门推荐
作为与百姓医疗健康息息相关的法律,药品管理法的修改工作备受关...
1天前 阅读: 940
日前,国务院新闻办公室举行政策例行会议,介绍短缺药品供应保障...
1天前 阅读: 1045
近日,恒瑞医药正式宣布进军医药零售。此讯息在业内引起无数猜想...
5天前 阅读: 2130
日前,新疆八师石河子市深化医药卫生体制改革领导小组办公室发布...
5天前 阅读: 2351
日前,据“汇聚南药”消息,2019年4月16日,唐山市与秦皇...
6天前 阅读: 3007
整个药品采购的过渡期,各色人物齐登场,什么李大哥、王大叔、张...
1星期前 阅读: 1725
人间四月天,百花争艳,药智数据企业版携手药智APP,在这春暖...
1星期前 阅读: 5117
4月18日(周四)13:30-17:00,“生物创享汇”第1...
1星期前 阅读: 2864
4月15日,药智网发起的《2019年中国CRO公司排行榜》评...
1星期前 阅读: 8356
【讲座】应用毒性预测软件满足ICH M7指导原则药智巡讲“2019年中国CRO公司排行榜”评选活动报名开启!2019第四届亚太医疗政策峰会PDI峰会cphi china药智APP2.2上新